Literature DB >> 15507752

Genetic studies on myeloperoxidase deficiency in Italy.

Caterina Marchetti1, Pierluigi Patriarca, G Pietro Solero, Francisco E Baralle, Maurizio Romano.   

Abstract

Hereditary myeloperoxidase (MPO) deficiency is the most common neutrophil biochemical defect characterized by the lack of peroxidase activity. In order to extend the epidemiological studies on hereditary MPO deficiency in Italy, approximately 40,000 individuals were analyzed and 7 partial and 8 total MPO deficient subjects were identified. The genetic characterization of the subjects showed the presence of 3 already-known mutations (c.752T>C, c.1705C>T and c.1566_1579del14) and 6 novel mutations: four missense mutations (c.995C>T, c.1112A>G, c.1715T>G and c.1927T>C), then a deletion of an adenine within exon 3 (c.325delA) and a mutation within the 3' splice site of intron 11 (c.2031-2A>C). The novel missense mutations cause the substitution of residues the p.A332V, p.D371G, p.L572W and p.W643R, respectively, and can cause potential structural changes. The c.325delA deletion causes a shift of the reading frame with the occurrence of a premature stop codon within the pro-peptide. An eukaryotic expression system was set up to investigate how the c.2031-2A>C mutation alters the MPO pre-mRNA splicing. The activation of a cryptic 3' splice site located 109nt upstream of the authentic 3' splice site was observed. The 109nt-insertion might cause the rapid degradation of the MPO mRNA or, alternatively, might lead to the generation of an abnormal MPO precursor lacking the enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507752

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  6 in total

1.  Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.

Authors:  Sunisa Kongkiatkamon; Laila Terkawi; Yihong Guan; Vera Adema; Metis Hasipek; Tatiana Dombrovski; Milo Co; Wencke Walter; Hassan Awada; Yvonne Parker; Stephan Hutter; Simona Pagliuca; Carmelo Gurnari; Heesun J Rogers; Manja Meggendorfer; Daniel J Lindner; Torsten Haferlach; Valeria Visconte; Thomas LaFramboise; Babal K Jha; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2022-06-27       Impact factor: 12.883

Review 2.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

3.  Biased exon/intron distribution of cryptic and de novo 3' splice sites.

Authors:  Jana Královicová; Mikkel B Christensen; Igor Vorechovský
Journal:  Nucleic Acids Res       Date:  2005-09-01       Impact factor: 16.971

4.  Aberrant 3' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.

Authors:  Igor Vorechovský
Journal:  Nucleic Acids Res       Date:  2006-09-08       Impact factor: 16.971

Review 5.  Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives.

Authors:  Amjad A Khan; Mohammed A Alsahli; Arshad H Rahmani
Journal:  Med Sci (Basel)       Date:  2018-04-18

6.  Prediction of the Effects of Missense Mutations on Human Myeloperoxidase Protein Stability Using In Silico Saturation Mutagenesis.

Authors:  Adebiyi Sobitan; William Edwards; Md Shah Jalal; Ayanfeoluwa Kolawole; Hemayet Ullah; Atanu Duttaroy; Jiang Li; Shaolei Teng
Journal:  Genes (Basel)       Date:  2022-08-08       Impact factor: 4.141

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.